To Compare the Efficacy and Safety of INS068 and Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin.
Clinical trial NCT05702073 · COMPLETED
Trial details
- NCT number
- NCT05702073
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-31
- Primary completion
- 2024-06-11
- Enrollment
- 423
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.